<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00501046</url>
  </required_header>
  <id_info>
    <org_study_id>KRM-307</org_study_id>
    <nct_id>NCT00501046</nct_id>
  </id_info>
  <brief_title>A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2)</brief_title>
  <official_title>A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of AST-120 for Prevention of Chronic Kidney Disease Progression in Patients With Moderate to Severe Chronic Kidney Disease Including Assessment of Quality of Life</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mitsubishi Tanabe Pharma Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kureha Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Mitsubishi Tanabe Pharma Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      1) To evaluate the effectiveness of AST-120 (spherical carbon adsorbent) added to
      standard-of-care therapy in moderate to severe Chronic Kidney Disease (CKD), on time to first
      occurrence of any event of the triple composite outcome of initiation of dialysis, kidney
      transplant or doubling of serum creatinine (sCr) when compared with placebo; 2) To evaluate
      the safety and tolerability of long-term AST-120 therapy in patients with CKD; 3) To evaluate
      the effects of AST-120 versus placebo, on other measures of renal function and quality of
      life.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2007</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite of Dialysis Initiation, Kidney Transplantation, and Serum Creatinine Doubling. Number of Participants Meeting the Criteria Are Reported.</measure>
    <time_frame>Beyond Week 48, a 12-week visit cycle continued until the end of the study or until individual patients reached an endpoint</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety and Tolerability</measure>
    <time_frame>approximately 42 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Development of a Component of a Quadruple Composite Endpoint (Initiation of Dialysis, Kidney Transplant, Doubling of sCr, or Death), Other Measures of Renal Function and (QOL: Exploratory)</measure>
    <time_frame>approximately 42 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vitamins and Folate Levels</measure>
    <time_frame>approximately 42 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1015</enrollment>
  <condition>Chronic Kidney Disease</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>AST-120</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>9g /day (3 times a day)</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>AST-120</intervention_name>
    <description>9g /day (3 times a day)</description>
    <arm_group_label>AST-120</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years or older

          -  Moderate to severe CKD, not anticipated to require dialysis or renal transplant within
             the next 6 months

          -  Patient survival expected to be no less than one year

          -  Serum creatinine in men &gt;= 2.0 mg/dL (&gt;= 177 µmol/L) and &lt;= 5.0 mg/dL (&lt;= 442 µmol/L),
             and in women &gt;= 1.5 mg/dL (&gt;= 133 µmol/L) and &lt;= 5.0 mg/dL (&lt;= 442 µmol/L) at
             Screening

          -  Urinary total protein to urinary total creatinine ratio must be &gt;= 0.5 on a spot void
             obtained at Screening

          -  Blood pressure &lt;= 160/90 mmHg at both Screening and Baseline visits. In addition,
             blood pressure, if measured, must have been stable in hypertensive patients over the 3
             months prior to Screening, with no more than 1 blood pressure reading &gt; 160/90 mmHg

          -  In patients being treated for hypertension, they should be on a stable
             anti-hypertensive regimen

        Exclusion Criteria:

          -  Obstructive or reversible cause of kidney disease

          -  Nephrotic syndrome defined as a ratio of urinary total protein to urinary creatinine
             of &gt; 6.0 as measured on a spot void

          -  Adult polycystic kidney disease

          -  History of previous kidney transplant

          -  History of recent (within the past 6 months) accelerated or malignant hypertension

          -  Uncontrolled arrhythmia or severe cardiac disease within the past 6 months

          -  History of malabsorption, inflammatory bowel disease, hiatal hernia, active peptic
             ulcer, or severe GI dysmotility, not attributable to the use of a phosphate binder

          -  Received any investigational agent or participated in a clinical study within the
             previous 3 months

          -  Presence of any significant medical condition that might create an undue risk with
             study participation, or significantly confound the collection of safety and efficacy
             data in this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Information at Mitsubishi Tanabe Pharma Development America, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Tuscaloosa</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hot Springs</city>
        <state>Arkansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bakersfield</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Glendale</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Riverside</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Boynton Beach</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>West Palm Beach</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Macon</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Evergreen Park</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Shawnee</city>
        <state>Kansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kenner</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pontiac</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Brooklyn Center</city>
        <state>Minnesota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Flushing</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Great Neck</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New York</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Williamsville</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Elizabeth City</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bend</city>
        <state>Oregon</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Doylestown</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lancaster</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Orangeburg</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sumter</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Arlington</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fairfax</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Suffolk</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vancouver</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cordoba</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tucumán</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Belo Horizonte</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Botucatu</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Campinas</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Curitiba</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ibirapuera</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Porto Alegre</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rio de Janeiro</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sorocaba</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>São Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Greenfield Park</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hradec Kralove</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Liberec</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Praha</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Usti nad Labem</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kiel</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mainz</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Aguascalientes</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cuernavaca</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Durango</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mexico City</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mexico</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bialystok</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Czestochowa</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lublin</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Warszawa</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>San Juan</city>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Arkhangelsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chelyabinsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ekaterinburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kemerovo</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Novosibirsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Orenburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Petrozavodsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Saratov</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>St. Petersburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tomsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Yaroslayl</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>A Coruña</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Asturias</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Guadalajara</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ivano-Frankivsk</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kharkov</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kiev</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lugansk</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lviv</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nikolaev</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Poltava</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ternopol</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vinnitsa</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Zaporizhzhya</city>
        <country>Ukraine</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Brazil</country>
    <country>Canada</country>
    <country>Czech Republic</country>
    <country>Germany</country>
    <country>Mexico</country>
    <country>Poland</country>
    <country>Puerto Rico</country>
    <country>Russian Federation</country>
    <country>Spain</country>
    <country>Ukraine</country>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Schulman G, Berl T, Beck GJ, Remuzzi G, Ritz E, Arita K, Kato A, Shimizu M. Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD. J Am Soc Nephrol. 2015 Jul;26(7):1732-46. doi: 10.1681/ASN.2014010042. Epub 2014 Oct 27.</citation>
    <PMID>25349205</PMID>
  </results_reference>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 11, 2007</study_first_submitted>
  <study_first_submitted_qc>July 11, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 13, 2007</study_first_posted>
  <results_first_submitted>February 15, 2015</results_first_submitted>
  <results_first_submitted_qc>February 15, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 2, 2015</results_first_posted>
  <disposition_first_submitted>October 1, 2012</disposition_first_submitted>
  <disposition_first_submitted_qc>October 1, 2012</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">October 5, 2012</disposition_first_posted>
  <last_update_submitted>March 2, 2015</last_update_submitted>
  <last_update_submitted_qc>March 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 20, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Kidney Diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>AST-120</title>
          <description>AST-120: 9g /day (3 times a day)</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Placebo: 9g /day (3 times a day)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="508"/>
                <participants group_id="P2" count="507"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="238"/>
                <participants group_id="P2" count="213"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="270"/>
                <participants group_id="P2" count="294"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Pregnancy</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="84"/>
                <participants group_id="P2" count="83"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Reaching endpoints,Noncompliance,etc</title>
              <participants_list>
                <participants group_id="P1" count="119"/>
                <participants group_id="P2" count="137"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>AST-120</title>
          <description>AST-120: 9g /day (3 times a day)</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Placebo: 9g /day (3 times a day)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="508"/>
            <count group_id="B2" value="507"/>
            <count group_id="B3" value="1015"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54.4" spread="15.52"/>
                    <measurement group_id="B2" value="55.7" spread="14.66"/>
                    <measurement group_id="B3" value="55.1" spread="15.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="229"/>
                    <measurement group_id="B2" value="226"/>
                    <measurement group_id="B3" value="455"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="279"/>
                    <measurement group_id="B2" value="281"/>
                    <measurement group_id="B3" value="560"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Composite of Dialysis Initiation, Kidney Transplantation, and Serum Creatinine Doubling. Number of Participants Meeting the Criteria Are Reported.</title>
        <time_frame>Beyond Week 48, a 12-week visit cycle continued until the end of the study or until individual patients reached an endpoint</time_frame>
        <population>ITT (censored at last contact)</population>
        <group_list>
          <group group_id="O1">
            <title>AST-120</title>
            <description>AST-120: 9g /day (3 times a day)</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: 9g /day (3 times a day)</description>
          </group>
        </group_list>
        <measure>
          <title>Composite of Dialysis Initiation, Kidney Transplantation, and Serum Creatinine Doubling. Number of Participants Meeting the Criteria Are Reported.</title>
          <population>ITT (censored at last contact)</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="500"/>
                <count group_id="O2" value="497"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="172"/>
                    <measurement group_id="O2" value="183"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Safety and Tolerability</title>
        <time_frame>approximately 42 months</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Development of a Component of a Quadruple Composite Endpoint (Initiation of Dialysis, Kidney Transplant, Doubling of sCr, or Death), Other Measures of Renal Function and (QOL: Exploratory)</title>
        <time_frame>approximately 42 months</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Vitamins and Folate Levels</title>
        <time_frame>approximately 42 months</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>The AE analysis is based on the Safety Population. The Safety Population included all patients who were randomized and received at least 1 dose of study drug. The start number of Participant Flow included all patients who were randomized.</desc>
      <group_list>
        <group group_id="E1">
          <title>AST-120</title>
          <description>AST-120: 9g /day (3 times a day)</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Placebo: 9g /day (3 times a day)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="156" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="178" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Haemolytic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Acute left ventricular failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis coronary artery</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Atrioventricular block</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Atrioventricular block complete</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Atrioventricular block first degree</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Atrioventricular block second degree</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Cardiac failure acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Cardiac failure chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy alcoholic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Coronary artery insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Ischaemic cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Left ventricular dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Silent myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Sinus bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Ventricular fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperparathyroidism tertiary</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Myxoedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Diabetic retinopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Diverticular perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Duodenitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Enterocolitis haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Erosive oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Gastritis erosive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Gastritis haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Impaired gastric emptying</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Large intestine perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Megacolon</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Mouth ulceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Pancreatic cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Pancreatitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Peptic ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Device difficult to use</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Device dislocation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Device lead damage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Generalised oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Multi-organ failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Necrobiosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Oedema due to renal disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Sudden cardiac death</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Sudden death</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Cholestasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Arteriovenous fistula site infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Arthritis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Bronchitis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Cholecystitis infective</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Diabetic gangrene</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Enterobacter sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Escherichia urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Lobar pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Myringitis bullous</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Pneumonia bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Pneumonia klebsiella</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Post procedural infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Pyelonephritis chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Staphylococcal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Streptococcal bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Subcutaneous abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Tooth abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Accidental overdose</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Arteriovenous fistula thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Gastrointestinal stoma complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Post procedural myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Postoperative ileus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Splenic rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Synovial rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Thermal burn</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Ulna fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Vascular access complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Chest X-ray abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Electrocardiogram QRS complex prolonged</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Haemoglobin decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Diabetic foot</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Electrolyte imbalance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Fluid overload</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hypercalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hypovolaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Metabolic acidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Gouty arthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Osteochondritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Cardiac myxoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Endometrial cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Gastrointestinal tract adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Metastases to liver</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Metastases to peritoneum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Parathyroid tumour benign</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Renal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of skin</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Autonomic neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Cerebral circulatory failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Cerebral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Encephalomyelitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Haemorrhagic stroke</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hepatic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hypoglycaemic coma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hypoglycaemic unconsciousness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Ischaemic cerebral infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Polyneuropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Radiculitis lumbosacral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Azotaemia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Calculus ureteric</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Diabetic nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Glomerulonephritis acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Glomerulonephritis chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Nephrotic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Oliguria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Renal failure chronic</sub_title>
                <counts group_id="E1" subjects_affected="34" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="47" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Dysfunctional uterine bleeding</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Ovarian cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Bronchitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Pulmonary congestion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Pulmonary hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Leukocytoclastic vasculitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Rash pruritic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Arteriovenous fistula operation</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Catheter placement</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Central venous catheterisation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Cholecystectomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Dialysis device insertion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Insertion of ambulatory peritoneal catheter</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Obesity surgery</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic aneurysm rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Haemodynamic instability</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hypertensive emergency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hypovolaemic shock</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="393" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="377" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="75" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="83" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperparathyroidism</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hyperparathyroidism secondary</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Eye haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="55" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="38" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="42" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="41" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Faeces discoloured</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Flatulence</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="45" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="45" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="36" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="46" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="57" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection viral</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="25" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="33" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood bicarbonate decreased</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Blood creatine phosphokinase increased</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Weight increased</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Acidosis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Dyslipidaemia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hypercalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hypercholesterolaemia</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="43" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="35" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hyperphosphataemia</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hypertriglyceridaemia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Metabolic acidosis</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Vitamin D deficiency</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="24" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Proteinuria</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Renal failure chronic</sub_title>
                <counts group_id="E1" subjects_affected="40" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="40" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="31" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Arteriovenous fistula operation</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="54" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="49" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="505"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="507"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="505"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Clinical Trials, Information Desk</name_or_title>
      <organization>Mitsubishi Tanabe Pharma Corporation</organization>
      <email>cti-inq-ml@ml.mt-pharma.co.jp</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

